Evidence map›Paper›PMID 38993721›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2024

Adipsic hypernatremia with marked hyperprolactinemia and GH deficiency in a 9-year-old boy.

Hisato Segoe, Akie Nakamura, Kimiaki Uetake, Nozomi Hishimura, Naoya Kaneko, Shuntaro Morikawa, Akari Nakamura-Utsunomiya, Takeshi Yamaguchi

Abstract readCase Reports
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hisato SegoeDepartment of Pediatrics, Obihiro-Kosei Hospital, Obihiro, Japan.
Akie NakamuraDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Kimiaki UetakeDepartment of Pediatrics, Obihiro-Kosei Hospital, Obihiro, Japan.
Nozomi HishimuraDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Naoya KanekoDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Shuntaro MorikawaDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Akari Nakamura-UtsunomiyaDepartment of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Takeshi YamaguchiDepartment of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipsic hypernatremia is typically caused by congenital dysplasia of the hypothalamus and pituitary or brain tumors. However, cases of adipsic hypernatremia without underlying organic abnormalities are rare, and some cases have been reported to be complicated by hypothalamic-pituitary dysfunction. The patient in this case was a 9-yr-old boy who was referred to our hospital because of hypernatremia. His growth chart revealed that he had rapidly become obese since infancy, with growth retardation since the age of seven. His hands and feet were very cold, and he had erythema on his abdomen, indicating possible autonomic dysregulation due to hypothalamic dysfunction. Several hormone load tests showed severe GH deficiency (GHD) and marked hyperprolactinemia (peak: 302.8 ng/mL). Magnetic resonance imaging revealed no organic abnormalities in the hypothalamus and pituitary gland. GH replacement therapy was initiated. Although his growth rate improved, obesity persisted. To the best of our knowledge, this is the first report of adipsic hypernatremia without organic intracranial abnormalities that was treated with GH. Moreover, the patient's prolactin levels were higher than those reported in previous studies. In conclusion, adipsic hypernatremia requires the evaluation of pituitary function and appropriate therapeutic interventions.

Indexed as

adipsic hypernatremiaGH deficiencyhyperprolactinemiahypothalamic-pituitary dysfunctionobesity

Identifiers

PMID38993721
PMCPMC11234189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.